MAFF and cancer: Moreover, analysis of the gene expression and survivability data for patients in the cancer genome atlas (TCGA) database revealed that the overall survival time of CAC patients with high MAFF gene expression was substantially longer than that of patients with low MAFF gene expression (p[HR]=0.038) (Figure 6F).